What are you looking for?

Library
Poster
Full Title

6-Aryl-β-Carbolines As Potent Tubulin-Polymerization Inhibitors


Authored by  P Blaney*, S Foster*, E Blaney*, S Hallworth*, A Smith*, P Doyle*, R Fisher*, A Teichert, G Lang, S Demotz, D McHugh, P Pospisil, FD Goffman

Presented at RSC ADVANCING THE CHEMICAL SCIENCES - HETEROCYCLIC & SYNTHESIS GROUP 21ST GRASMERE MEETING    
* This author is not affiliated with PMI.

Abstract

Natural products have proven to be an excellent resource for discovering new potential drug candidates. For example, a recent study has shown that 64% of anti-cancer drugs and 76% of anti-bacterial drugs are natural products or derivatives.

1. Within a program aimed at the exploration of the biological activities of semisynthetic libraries based on natural product scaffolds – one of which was harmane 1 – 6-aryl-β-carbolines

2. Were identified as potent cytotoxic agents with an in vivo anti-tumour activity. The underlying mechanism was found to be microtubulin depolymerization by interaction with the colchicine binding site. 

6-aryl-β-carbolines-as-potent-tubulin-polymerization-inhibitors

Our RRPs

Reduced-risk products ("RRPs") is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.